566 related articles for article (PubMed ID: 27956387)
1. Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia.
Powell JA; Lewis AC; Zhu W; Toubia J; Pitman MR; Wallington-Beddoe CT; Moretti PA; Iarossi D; Samaraweera SE; Cummings N; Ramshaw HS; Thomas D; Wei AH; Lopez AF; D'Andrea RJ; Lewis ID; Pitson SM
Blood; 2017 Feb; 129(6):771-782. PubMed ID: 27956387
[TBL] [Abstract][Full Text] [Related]
2. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells.
Xu L; Zhang Y; Gao M; Wang G; Fu Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060
[TBL] [Abstract][Full Text] [Related]
3. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
4. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
[TBL] [Abstract][Full Text] [Related]
5. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
Tanfin Z; Serrano-Sanchez M; Leiber D
Cell Signal; 2011 Dec; 23(12):1997-2004. PubMed ID: 21803151
[TBL] [Abstract][Full Text] [Related]
6. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
[TBL] [Abstract][Full Text] [Related]
7. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma.
Chen MH; Yen CC; Cheng CT; Wu RC; Huang SC; Yu CS; Chung YH; Liu CY; Chang PM; Chao Y; Chen MH; Chen YF; Chiang KC; Yeh TS; Chen TC; Huang CY; Yeh CN
Oncotarget; 2015 Sep; 6(27):23594-608. PubMed ID: 26090720
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
Gorshkova IA; Wang H; Orbelyan GA; Goya J; Natarajan V; Beiser DG; Vanden Hoek TL; Berdyshev EV
Life Sci; 2013 Sep; 93(9-11):359-66. PubMed ID: 23892195
[TBL] [Abstract][Full Text] [Related]
9. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.
Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D
Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis.
Karimian G; Buist-Homan M; Schmidt M; Tietge UJ; de Boer JF; Klappe K; Kok JW; Combettes L; Tordjmann T; Faber KN; Moshage H
Biochim Biophys Acta; 2013 Dec; 1832(12):1922-9. PubMed ID: 23816565
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation.
Hirata N; Yamada S; Shoda T; Kurihara M; Sekino Y; Kanda Y
Nat Commun; 2014 Sep; 5():4806. PubMed ID: 25254944
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP
Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351
[TBL] [Abstract][Full Text] [Related]
14. Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity.
Chakraborty P; Vaena SG; Thyagarajan K; Chatterjee S; Al-Khami A; Selvam SP; Nguyen H; Kang I; Wyatt MW; Baliga U; Hedley Z; Ngang RN; Guo B; Beeson GC; Husain S; Paulos CM; Beeson CC; Zilliox MJ; Hill EG; Mehrotra M; Yu XZ; Ogretmen B; Mehrotra S
Cell Rep; 2019 Aug; 28(7):1879-1893.e7. PubMed ID: 31412253
[TBL] [Abstract][Full Text] [Related]
15. Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia.
Moujalled DM; Pomilio G; Ghiurau C; Ivey A; Salmon J; Rijal S; Macraild S; Zhang L; Teh TC; Tiong IS; Lan P; Chanrion M; Claperon A; Rocchetti F; Zichi A; Kraus-Berthier L; Wang Y; Halilovic E; Morris E; Colland F; Segal D; Huang D; Roberts AW; Maragno AL; Lessene G; Geneste O; Wei AH
Leukemia; 2019 Apr; 33(4):905-917. PubMed ID: 30214012
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of genes regulated by sphingosine kinase1 signaling in a murine model of hyperoxia induced neonatal bronchopulmonary dysplasia.
Natarajan V; Ha AW; Dong Y; Reddy NM; Ebenezer DL; Kanteti P; Reddy SP; Usha Raj J; Lei Z; Maienschein-Cline M; Arbieva Z; Harijith A
BMC Genomics; 2017 Aug; 18(1):664. PubMed ID: 28851267
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models.
Pchejetski D; Doumerc N; Golzio M; Naymark M; TeissiƩ J; Kohama T; Waxman J; Malavaud B; Cuvillier O
Mol Cancer Ther; 2008 Jul; 7(7):1836-45. PubMed ID: 18644996
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.
Zhang F; Xia Y; Yan W; Zhang H; Zhou F; Zhao S; Wang W; Zhu D; Xin C; Lee Y; Zhang L; He Y; Gao E; Tao L
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H250-61. PubMed ID: 26589326
[TBL] [Abstract][Full Text] [Related]
19. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
[TBL] [Abstract][Full Text] [Related]
20. Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells.
Fiskus W; Cai T; DiNardo CD; Kornblau SM; Borthakur G; Kadia TM; Pemmaraju N; Bose P; Masarova L; Rajapakshe K; Perera D; Coarfa C; Mill CP; Saenz DT; Saenz DN; Sun B; Khoury JD; Shen Y; Konopleva M; Bhalla KN
Blood Cancer J; 2019 Jan; 9(2):4. PubMed ID: 30647404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]